Nanoparticles have received much attention recently due to their use in cancer therapy.
Studies have shown that different metal oxide nanoparticles induce cytotoxicity in cancer …

Dendritic cell-based cancer immunotherapy requires tumour antigens to be delivered
efficiently into dendritic cells and their migration to be monitored in vivo. Nanoparticles have …

Pancreatic adenocarcinoma is the fourth leading cause of cancer death with an overall 5-
year survival of less than 5%. As there is ample evidence that pancreatic adenocarcinomas …

Nanomaterial-based tumor photothermal therapy (PTT) has attracted increasing attention
and been a promising method for cancer treatment because of its low level of adverse …

Effective processing and cross-priming of tumor neoantigen by dendritic cells (DCs) to T
cells for spontaneous immune response generation to effectively kill cancer cells remain …

Zinc oxide (ZnO)-based nanocomposites have shown promising potential for various
biomedical applications, including vaccine development, owing to their multifunctionality …

Immunotherapies are increasingly used to treat cancer, with some outstanding results.
Immunotherapy modalities include therapeutic vaccination to eliminate cancer cells through …

Carcinoembryonic antigen (CEA), a glycosylated protein of MW 180 kDa, is overexpressed
in a wide range of human carcinomas, including colorectal, gastric, pancreatic, non-small …

Cancer immunotherapy has shown promising therapeutic results in the clinic, albeit only in a
limited number of cancer types, and its efficacy remains less than satisfactory. Nanoparticle …

A major challenge for the development of anticancer vaccines is the induction of a safe and
effective immune response, particularly mediated by CD8+ T lymphocytes, in an adjuvant …